Issa Mohamed Khairie
CIK 2050035 · EVP, Head of US Oncology · last filed 2026-01-21
Issa Mohamed Khairie is an EVP, Head of US Oncology who has filed 5 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for INCY, was dated Jan 21, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.83M
1
5
-$1.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | EVP, Head of US Oncology | 66,132 | $103.23 | $6.83M | -$1.18M | 5 | 2026-01-21 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-21 | INCY | Grant (A) | — | $0 | EDGAR |
| 2026-01-08 | INCY | Mixed | −19,120 | -$2.07M | EDGAR |
| 2025-07-17 | INCY | Grant (A) | +8,769 | $0 | EDGAR |
| 2025-07-02 | INCY | Grant (A) | +27,812 | $0 | EDGAR |
| 2025-01-08 | INCY | Grant (A) | +48,671 | $0 | EDGAR |